home · filing · 0001104659-21-134050
8-K
filed November 4, 2021, 7:59 PM ET
ticker MTVA
CIK 0001638287
leadership
confidence high
sentiment neutral
materiality 0.70
NeuroBo appoints Gil Price as CEO; Richard Kang resigns with $150k severance
MetaVia Inc.
CEO Richard Kang resigned Nov 3, 2021; remains on Board and will consult for up to one year at $10,000/month.
Kang receives $150,000 severance, $130,680 prorated 2021 bonus, and up to 12 months COBRA reimbursement.
Gil Price appointed CEO, President, Principal Executive and Financial Officer; base salary $400,000, target bonus 50%.
Board adopted 2021 Inducement Plan, reserving 1,000,000 shares for equity grants to new hires without stockholder approval.
Price granted inducement option for 616,666 shares at $2.04 (closing price Nov 3, 2021); vests over two years.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2021-11-03
Filed November 4, 2021, 7:59 PM ET
Richard Kang, Ph.D. resigned from his positions as Chief Executive Officer and President of the Company, effective as of November 3, 2021
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Richard Kang resigned as Chief Executive Officer and President at MetaVia Inc..
Action resigned
Role Chief Executive Officer and President
Exact text from the filing
Richard Kang, Ph.D. resigned from his positions as Chief Executive Officer and President of the Company, effective as of November 3, 2021
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-21-134050
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.